Effectiveness of deferiprone-loaded nanocarrier in experimentally induced rhabdomyolysis: A dose-comparison study
- 5 May 2020
- journal article
- research article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 100, 103913
- https://doi.org/10.1016/j.bioorg.2020.103913
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Water Soluble Polymers for Pharmaceutical ApplicationsPolymers, 2011
- The Effect Of The Oral Iron Chelator Deferiprone On The Liver Damage Induced By Tamoxifen In Female RatsHemoglobin, 2011
- Pharmacological investigations of Punica granatum in glycerol-induced acute renal failure in ratsIndian Journal of Pharmacology, 2011
- DeferiproneAnnals of the New York Academy of Sciences, 2010
- Desferrioxamine Inhibits Production of Cytotoxic Heme to Protein Cross-Linked Myoglobin: A Mechanism to Protect against Oxidative Stress without Iron ChelationChemical Research in Toxicology, 2005
- Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significanceEuropean Heart Journal, 2004
- Effect of temperature on aggregation/dissociation behavior of interpolymer complexes stabilized by hydrogen bondsJournal of Applied Polymer Science, 2004
- Role of deferiprone in chelation therapy for transfusional iron overloadBlood, 2003
- Effects of inorganic iron and myoglobin on in vitro proximal tubular lipid peroxidation and cytotoxicity.JCI Insight, 1992
- Plasmakreatinin als grober Indikator der Nierenfunktion*Deutsche Medizinische Wochenschrift (1946), 1964